vsbc_ex321.htm

EX-32.1 4 vsbc_ex321.htm CERTIFICATION vsbc_ex321.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of VitaSpring Biomedical Co., Ltd (the “Company”) on Form 10-K for the years ended January 31, 2023 and January 31, 2022, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Ssu-Chuan Lai, the Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 1, 2025

/s/ Ssu-Chuan Lai

Ssu-Chuan Lai

Chief Executive Officer

(Principal Executive Officer)

	1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 1, 2025	/s/ Ssu-Chuan Lai
	Ssu-Chuan Lai
	Chief Executive Officer
	(Principal Executive Officer)